213 related articles for article (PubMed ID: 36504796)
41. [Overview of Meta-analysis of Lianhua Qingwen preparations in treatment of viral diseases].
Li WF; Hu CC; Ding YL; Yuan B
Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(16):4505-4516. PubMed ID: 36046880
[TBL] [Abstract][Full Text] [Related]
42. Picroside II Improves Severe Acute Pancreatitis-Induced Intestinal Barrier Injury by Inactivating Oxidative and Inflammatory TLR4-Dependent PI3K/AKT/NF-
Piao X; Liu B; Sui X; Li S; Niu W; Zhang Q; Shi X; Cai S; Fan Y
Oxid Med Cell Longev; 2020; 2020():3589497. PubMed ID: 32351672
[TBL] [Abstract][Full Text] [Related]
43. Yiyi Fuzi Baijiang Powder Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Rats via Inhibiting the TLR4/NF-
Yang J; Miao L; Xue Y; Wang X
Oxid Med Cell Longev; 2023; 2023():3071610. PubMed ID: 36691639
[TBL] [Abstract][Full Text] [Related]
44. The efficacy and safety of Lianhua Qingwen (LHQW) for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis.
Zhang Q; Cao F; Ji G; Xu X; Sun Y; Li J; Qi X; Sun S; Wang Y; Song B
Medicine (Baltimore); 2020 Jul; 99(30):e20979. PubMed ID: 32791675
[TBL] [Abstract][Full Text] [Related]
45. Uncovering the pharmacological mechanisms of Xijiao Dihuang decoction combined with Yinqiao powder in treating influenza viral pneumonia by an integrative pharmacology strategy.
Guo R; Zhao M; Liu H; Su R; Mao Q; Gong L; Cao X; Hao Y
Biomed Pharmacother; 2021 Sep; 141():111676. PubMed ID: 34126353
[TBL] [Abstract][Full Text] [Related]
46. GeGen QinLian decoction alleviate influenza virus infectious pneumonia through intestinal flora.
Deng L; Shi Y; Liu P; Wu S; Lv Y; Xu H; Chen X
Biomed Pharmacother; 2021 Sep; 141():111896. PubMed ID: 34246956
[TBL] [Abstract][Full Text] [Related]
47. Dysbiosis of Gut Microbiota and Intestinal Barrier Dysfunction in Pigs with Pulmonary Inflammation Induced by Mycoplasma hyorhinis Infection.
Zhang Y; Gan Y; Wang J; Feng Z; Zhong Z; Bao H; Xiong Q; Wang R
mSystems; 2022 Aug; 7(4):e0028222. PubMed ID: 35699454
[TBL] [Abstract][Full Text] [Related]
48. [Systematic review of efficacy and safety of Lianhua Qingwen Capsules in treatment of viral influenza].
Wang SH; Liu JF; Zhang YL; Dong Z
Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(7):1503-1508. PubMed ID: 31090311
[TBL] [Abstract][Full Text] [Related]
49. The protective effects of Mai-Luo-Ning injection against LPS-induced acute lung injury via the TLR4/NF-κB signalling pathway.
Miao J; Shen J; Yan C; Ren J; Liu H; Qiao Y; Li Q
Phytomedicine; 2022 Sep; 104():154290. PubMed ID: 35793597
[TBL] [Abstract][Full Text] [Related]
50. Qin-Qiao-Xiao-Du formula alleviate influenza virus infectious pneumonia through regulation gut microbiota and metabolomics.
Lian B; He S; Jiang H; Guo Y; Cui X; Jiang T; Su R; Chen Y; Zhao C; Zhang M; Hu Y; Ye H; Ning J; Xu X; Liu Q
Front Med (Lausanne); 2022; 9():1032127. PubMed ID: 36313993
[TBL] [Abstract][Full Text] [Related]
51. Emodin Inhibition of Influenza A Virus Replication and Influenza Viral Pneumonia via the Nrf2, TLR4, p38/JNK and NF-kappaB Pathways.
Dai JP; Wang QW; Su Y; Gu LM; Zhao Y; Chen XX; Chen C; Li WZ; Wang GF; Li KS
Molecules; 2017 Oct; 22(10):. PubMed ID: 29057806
[TBL] [Abstract][Full Text] [Related]
52. Puerarin reduces impairment of intestinal and adipose immune responses to influenza virus infection in mice.
Zeng MS; Yu WD; Wang HX; Xu PP; Liu JY
Arch Virol; 2021 Sep; 166(9):2387-2397. PubMed ID: 34114139
[TBL] [Abstract][Full Text] [Related]
53. Resveratrol Attenuates Ankylosing Spondylitis in Mice by Inhibiting the TLR4/NF-κB/NLRP3 Pathway and Regulating Gut Microbiota.
Ding MH; Xu PG; Wang Y; Ren BD; Zhang JL
Immunol Invest; 2023 Feb; 52(2):194-209. PubMed ID: 36548483
[TBL] [Abstract][Full Text] [Related]
54. Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and inhibition of TLR4/MyD88/NF-κB pathway.
Zhu Y; Han Q; Wang L; Wang B; Chen J; Cai B; Wu C; Zhu X; Liu F; Han D; Dong H; Jia Y; Liu Y
J Ethnopharmacol; 2023 Jan; 301():115763. PubMed ID: 36183949
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of Lianhua Qingwen for children with SARS-CoV-2 Omicron infection: A propensity score-matched retrospective cohort study.
Xu X; Wu H; Jin G; Huang J; Li J; Zhou J; Cao M; Sun D; Zhang W; Peng W; Pu Y; Chen C; Sun Y; Yang H; Zhou S; Fang B
Phytomedicine; 2023 Mar; 111():154665. PubMed ID: 36641977
[TBL] [Abstract][Full Text] [Related]
56. Effect of Bining decoction on gouty nephropathy: a network pharmacology analysis and preliminary validation of gut microbiota in a mouse model.
Huang H; Tong Y; Fu T; Lin D; Li H; Xu L; Zhang S; Yin Y; Gao Y
Ann Transl Med; 2022 Dec; 10(23):1271. PubMed ID: 36618800
[TBL] [Abstract][Full Text] [Related]
57. Screening for Anti-Inflammation Quality Markers of Lianhua Qingwen Capsule Based on Network Pharmacology, UPLC, and Biological Activity.
Zhou Y; Niu M; Zhang D; Liu Z; Wu Q; Chen J; Zhang H; Zhang P; Pei J
Front Pharmacol; 2021; 12():648439. PubMed ID: 34177573
[TBL] [Abstract][Full Text] [Related]
58. Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency.
Qi-Xiang M; Yang F; Ze-Hua H; Nuo-Ming Y; Rui-Long W; Bin-Qiang X; Jun-Jie F; Chun-Lan H; Yue Z
Gut Microbes; 2022; 14(1):2112882. PubMed ID: 35982604
[TBL] [Abstract][Full Text] [Related]
59. Houttuynia cordata polysaccharide alleviated intestinal injury and modulated intestinal microbiota in H1N1 virus infected mice.
Chen MY; Li H; Lu XX; Ling LJ; Weng HB; Sun W; Chen DF; Zhang YY
Chin J Nat Med; 2019 Mar; 17(3):187-197. PubMed ID: 30910055
[TBL] [Abstract][Full Text] [Related]
60. [Mechanism of tonifying Qi traditional Chinese medicines contained in Yiqi Qingwen Jiedu mixture against influenza immune inflammatory injury].
Xu HR; Wang CX; Wang L; Zhou PA; Yin RY; Jiang LD; Wang HF
Zhongguo Zhong Yao Za Zhi; 2014 Oct; 39(20):4020-6. PubMed ID: 25751956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
